182 related articles for article (PubMed ID: 16463427)
1. Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis.
Weidner S; Hafezi-Rachti S; Rupprecht HD
Arthritis Rheum; 2006 Feb; 55(1):146-9. PubMed ID: 16463427
[No Abstract] [Full Text] [Related]
2. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
Kötter I
Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987
[No Abstract] [Full Text] [Related]
3. [Antineutrophil cytoplasmic antibodies and associated diseases].
Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
[TBL] [Abstract][Full Text] [Related]
4. Increased serum levels of soluble triggering receptor expressed on myeloid cells-1 in antineutrophil cytoplasmic antibody-associated vasculitis.
Daikeler T; Regenass S; Tyndall A; Gencay MM; Roth M; Christ-Crain M; Müller B; Hess C
Ann Rheum Dis; 2008 May; 67(5):723-4. PubMed ID: 18408110
[No Abstract] [Full Text] [Related]
5. Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approaches to management.
Little MA; Pusey CD
Nephrology (Carlton); 2005 Aug; 10(4):368-76. PubMed ID: 16109084
[TBL] [Abstract][Full Text] [Related]
6. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known.
de Lind van Wijngaarden RA; van Rijn L; Hagen EC; Watts RA; Gregorini G; Tervaert JW; Mahr AD; Niles JL; de Heer E; Bruijn JA; Bajema IM
Clin J Am Soc Nephrol; 2008 Jan; 3(1):237-52. PubMed ID: 18077783
[TBL] [Abstract][Full Text] [Related]
7. Propylthiouracil and antineutrophil cytoplasmic antibody associated vasculitis: the detective finds a clue.
Pillinger MH; Staud R
Semin Arthritis Rheum; 2006 Aug; 36(1):1-3. PubMed ID: 16887462
[No Abstract] [Full Text] [Related]
8. Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors.
Stassen PM; Derks RP; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2008 Apr; 47(4):530-4. PubMed ID: 18356178
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolic complications after spinal surgery in trauma patients.
Platzer P; Thalhammer G; Jaindl M; Obradovic A; Benesch T; Vecsei V; Gaebler C
Acta Orthop; 2006 Oct; 77(5):755-60. PubMed ID: 17068706
[TBL] [Abstract][Full Text] [Related]
10. Membranous nephropathy and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: a report of 2 cases.
Dwyer KM; Agar JW; Hill PA; Murphy BF
Clin Nephrol; 2001 Nov; 56(5):394-7. PubMed ID: 11758012
[No Abstract] [Full Text] [Related]
11. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
12. Isolated polyarthritis followed by systemic polyangiitis with antineutrophil cytoplasmic antibody.
Goument C; Alcaix D; Zarnitsky C
Rev Rhum Engl Ed; 1998 Jan; 65(1):78. PubMed ID: 9523394
[No Abstract] [Full Text] [Related]
13. Absence of anti-cyclic citrullinated peptide antibodies in antineutrophil cytoplasmic antibody-associated vasculitis.
Tervaert JW; Damoiseaux J; Boomsma MM; Stegeman CA
Arthritis Rheum; 2002 Mar; 46(3):849-50. PubMed ID: 11920433
[No Abstract] [Full Text] [Related]
14. Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-associated vasculitis: a pilot study of 21 patients.
Hasegawa M; Ohashi A; Kabutan N; Hiramatsu S; Kato M; Murakami K; Tomita M; Nabeshima K; Hiki Y; Sugiyama S
Ther Apher Dial; 2006 Oct; 10(5):412-8. PubMed ID: 17096695
[TBL] [Abstract][Full Text] [Related]
15. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism after uterine fibroid embolization.
Czeyda-Pommersheim F; Magee ST; Cooper C; Hahn WY; Spies JB
Cardiovasc Intervent Radiol; 2006; 29(6):1136-40. PubMed ID: 16810461
[TBL] [Abstract][Full Text] [Related]
17. Large vessel compromise in antineutrophil cytoplasmic antibody-associated systemic vasculitis: comment on the article by Booth et al.
Chirinos JA; Tamariz LJ; Lichtstein DL
Arthritis Rheum; 2004 Oct; 50(10):3398-9; author reply 3399-400. PubMed ID: 15476214
[No Abstract] [Full Text] [Related]
18. Antineutrophil cytoplasmic antibody-associated vasculitis: autoinflammation, autodestruction and autoimmunity--key to new therapies.
Lamprecht P; Gross WL
Trends Immunol; 2008 Dec; 29(12):587-8. PubMed ID: 18951843
[No Abstract] [Full Text] [Related]
19. Prevalence of antineutrophil cytoplasmic antibodies during treatment with benzylthiouracil.
Sghiri R; Ouertani M; Ben Hsine H; Slim I; Chaieb L; Ghedira I
Pathol Biol (Paris); 2009 Jul; 57(5):410-4. PubMed ID: 19201108
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibody associated vasculitis and renal failure in Behçet's disease.
Khan IH; Catto GR; MacLeod AM
Nephrol Dial Transplant; 1994; 9(3):332. PubMed ID: 8052448
[No Abstract] [Full Text] [Related]
[Next] [New Search]